|
JAK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19669996134775E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03979996729709E-09 |
| Normal-vs-Stage2 |
1.027830E-02 |
| Normal-vs-Stage3 |
2.9907999965495E-08 |
| Normal-vs-Stage4 |
1.219950E-03 |
| Stage1-vs-Stage2 |
2.345200E-01 |
| Stage1-vs-Stage3 |
5.913800E-01 |
| Stage1-vs-Stage4 |
3.100400E-01 |
| Stage2-vs-Stage3 |
8.307900E-02 |
| Stage2-vs-Stage4 |
6.146300E-02 |
| Stage3-vs-Stage4 |
3.091200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.31580002238741E-10 |
| Normal-vs-AfricanAmerican |
2.1628999999912E-06 |
| Normal-vs-Asian |
2.808800E-04 |
| Caucasian-vs-AfricanAmerican |
4.247000E-01 |
| Caucasian-vs-Asian |
7.696400E-01 |
| AfricanAmerican-vs-Asian |
5.354000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32099894859061E-11 |
| Normal-vs-Female |
8.557200E-03 |
| Male-vs-Female |
3.680200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.13169999985219E-07 |
| Normal-vs-Extreme_Weight |
1.10909947892424E-10 |
| Normal-vs-Obese |
5.160600E-04 |
| Normal-vs-Extreme_Obese |
1.93072999999933E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.008600E-01 |
| Normal_Weight-vs-Obese |
1.937770E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.028000E-01 |
| Extreme_Weight-vs-Obese |
8.683600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.885200E-01 |
| Obese-vs-Extreme_Obese |
2.122800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.794760E-04 |
| Normal-vs-Age(41-60Yrs) |
5.95229999955649E-07 |
| Normal-vs-Age(61-80Yrs) |
2.31900054714629E-10 |
| Normal-vs-Age(81-100Yrs) |
3.72250000000296E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.032400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.182800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.275200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.320300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.985000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.364800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.27929922000681E-11 |
| Normal-VS-Type2 PRCC |
5.68549999968582E-07 |
| Normal-VS-KIRP CIMP |
1.021050E-03 |
| Normal-VS-Unclassified PRCC |
2.578600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.482000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.812000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.031800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.638600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.210200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.237200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.74330000330048E-09 |
| Normal-vs-N1 |
3.63760000000601E-05 |
| Normal-vs-N2 |
1.53640000000177E-06 |
| N0-vs-N1 |
8.411200E-01 |
| N0-vs-N2 |
1.547820E-01 |
| N1-vs-N2 |
1.520780E-01 |
|
|
